Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
Sales | 5,224 | 5,249 | 3,735 | 5,435 | 16,694 |
Gross Profit | 5,224 | 5,249 | 3,735 | 5,435 | 16,694 |
Operating Expenses | 16,264 | 18,054 | 17,978 | 16,934 | 27,002 |
Operating Income | -11,040 | -12,805 | -14,243 | -11,499 | -10,308 |
Interest Expense | 1,160 | 1,160 | 1,166 | 288 | 0 |
Other Income | -991 | -494 | -862 | -1,240 | 107 |
Pre-tax Income | -13,191 | -14,459 | -16,271 | -13,027 | -10,201 |
Net Income Continuous | -13,191 | -14,459 | -16,271 | -13,027 | -10,201 |
Net Income | $-13,191 | $-14,459 | $-16,271 | $-13,027 | $-10,201 |
EPS Basic Total Ops | -0.29 | -0.32 | -0.36 | -0.29 | -0.23 |
EPS Basic Continuous Ops | -0.29 | -0.32 | -0.36 | -0.29 | -0.23 |
EPS Diluted Total Ops | -0.29 | -0.32 | -0.36 | -0.29 | -0.23 |
EPS Diluted Continuous Ops | -0.29 | -0.32 | -0.36 | -0.29 | -0.23 |
EBITDA(a) | $-10,674 | $-12,511 | $-13,917 | $-11,243 | $-9,138 |